Magazine Contents

Nikkei BusinessNikkei Business

Nikkei Business

August 5, 2024

Special Feature 1:

Softbank, Suntory, Fujikura
How the third biggest companies in their respective industries are winning out

Special Feature 2:

Ono Pharmaceutical Co., Ltd.
Patent about to expire on chemotherapy drug Opdivo
---Risk of a 60% loss in sales---
Shoring up business in the U.S. and Europe through M&As

A Bird’s-eye View:

China steps up censorship on AI
How AI answers the question: “Is Xi Jinping a great leader?”

News in Depth:

Abnormal weather patterns disrupt food sources around the world
---Disappearing orange juice---

Back to List